If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Filippo Ballerini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 75 Similar Profiles
Thalidomide Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Cytarabine Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Idarubicin Medicine & Life Sciences
Salvage Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

  • 736 Citations
  • 12 h-Index
  • 42 Article
  • 2 Letter

A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia

Marcolin, R., Guolo, F., Minetto, P., Clavio, M., Manconi, L., Ballerini, F., Carli, A., Passannante, M., Colombo, N., Carminati, E., Pugliese, G., Tedone, E., Contini, P., Mangerini, R., Kunkl, A., Miglino, M., Cagnetta, A., Cea, M., Gobbi, M. & Lemoli, R. M., Nov 1 2019, In : Leukemia Research. 86, 106223.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Mutation
HLA-DR Antigens
Karyotype
Multivariate Analysis

Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas

Manconi, L., Coviello, E., Canale, F., Giannoni, L., Minetto, P., Guolo, F., Clavio, M., Marcolin, R., Cea, M., Cagnetta, A., Gobbi, M., Miglino, M., Ballerini, F. & Lemoli, R. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

oxaliplatin
Lymphoma, Large B-Cell, Diffuse
Cytarabine
Cell- and Tissue-Based Therapy
Dexamethasone

Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach

Guolo, F., Minetto, P., Clavio, M., Miglino, M., Colombo, N., Cagnetta, A., Cea, M., Marcolin, R., Todiere, A., Ballerini, F., Gobbi, M. & Lemoli, R. M., Sep 1 2019, In : British Journal of Haematology. 186, 6, p. e223-e225

Research output: Contribution to journalLetter

3 Citations (Scopus)

Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

Minetto, P., Guolo, F., Clavio, M., Kunkl, A., Colombo, N., Carminati, E., Fugazza, G., Matarese, S., Guardo, D., Ballerini, F., Di Grazia, C., Raiola, A. M., Cagnetta, A., Cea, M., Miglino, M., Lemoli, R. M. & Gobbi, M., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)

Stefoni, V., Pellegrini, C., Broccoli, A., Baldini, L., Tani, M., Cencini, E., Figuera, A., Ansuinelli, M., Bernocco, E., Cantonetti, M., Cox, M. C., Ballerini, F., Rusconi, C., Visco, C., Arcaini, L., Fama, A., Marasca, R., Volpetti, S., Castellino, A., Califano, C. & 8 others, Cavaliere, M., Gini, G., Liberati, A. M., Musuraca, G., Lucania, A., Ricciuti, G., Argnani, L. & Zinzani, P. L., Sep 2018, In : The oncologist. 23, 9, p. 1033-1038 6 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Multicenter Studies
Retrospective Studies
Disease-Free Survival
lenalidomide